Armata Pharmaceuticals Inc. (NYSE American: ARMP) announced the FDA has agreed to advance its bacteriophage drug candidate AP-SA02 to a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE